ReviewRSC advances2026
Coumarin hybrids as privileged therapeutic scaffolds: biological activities, mechanistic insights, and therapeutic potential.
Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coumarin-based scaffolds have emerged as versatile structural platforms in modern medicinal chemistry due to their broad pharmacological spectrum and ease of functional modification. This review provides a comprehensive and up-to-date analysis of coumarin hybrid molecules reported between 2022 and 2026, highlighting recent advances in biological evaluation and its mechanistic understanding. Particular emphasis is placed on structurally diverse hybrids such as urea, hydroxamate, triazole-isatin, thiadiazole, and other multifunctional coumarin derivatives developed as therapeutic candidates across oncology, neurodegenerative disorders, and antimicrobial research. A systematic structure-activity relationship (SAR) discussion reveals that biological performance is strongly influenced by substitution patterns on the coumarin ring, linker length and flexibility, and the presence of pharmacophoric fragments enabling metal coordination, hydrogen bonding, and π-interactions. Hence, this review highlights the therapeutic significance of coumarin hybrids and their potential as promising lead scaffolds for future drug development.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.